The FDA expanded the approvals of Bayer’s Gadavist MRI contrast agent, clearing it to help gauge the blood supply of the heart muscle as well as the rates of myocardial perfusion at rest and during ...
Bayer AG (OTCMKTS:BAYRY) is among the best German stocks to buy according to analysts. On March 5, Bayer AG (OTCMKTS:BAYRY) announced that the FDA has cleared its MEDRAD MRXperion MR injector system ...
Bayer revealed first results of the pediatric study from the pivotal clinical development program QUANTI for its low-dose MRI contrast agent QUANTI Pediatric evaluated the pharmacokinetics and safety ...
Bayer AG on Monday said U.S. regulators approved its contrast agent for use in magnetic resonance imaging (MRI) to assess patients with known or suspected coronary artery disease. July 15 (Reuters) - ...
The radiology division of drugmaker Bayer is taking a step beyond its portfolio of devices for delivering contrast dyes for CT and MRI scans and moving into digital and artificial-intelligence-powered ...
MENLO PARK, Calif.--(BUSINESS WIRE)--HALO Precision Diagnostics (“HALO”), a leader in early disease detection using precision diagnostics, today announced a collaboration with Bayer, a global leader ...
Bayer BAYRY announced that it has submitted a new drug application (“NDA”) to the FDA seeking approval for its investigational low-dose gadolinium-based contrast agent (“GBCA”), gadoquatrane, for use ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results